Invited Commentary
June 2014

When Does Peer Support Improve Glycemic Control in Persons With Diabetes Mellitus?

Author Affiliations
  • 1Primary Care Division, Clement J. Zablocki VA Medical Center, Milwaukee, Wisconsin
  • 2Center for Patient Care Outcomes Research, Medical College of Wisconsin, Milwaukee
  • 3Division of General Internal Medicine, Department of Medicine, Medical College of Wisconsin, Milwaukee

Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.

JAMA Intern Med. 2014;174(6):982-983. doi:10.1001/jamainternmed.2014.654

Diabetes mellitus (DM) is a common, morbid, and costly disease. In the United States, it affects more than 1 in 10 adults. It is the leading cause of new blindness, amputation, and end-stage renal disease and contributes to a host of other conditions. In 2011, the medical costs of managing DM and its complications exceeded $115 billion in the United States alone; indirect costs added another $58 billion.1 Because there is strong evidence that the complications can be markedly attenuated with appropriate control of blood pressure and hyperglycemia and with statin treatment of hyperlipidemia, it is not surprising that there is great interest in novel approaches to management.

First Page Preview View Large
First page PDF preview
First page PDF preview